Cerebrospinal fluid soluble CD27 levels in children with non-Hodgkin lymphomas

Pediatr Hematol Oncol. 2004 Dec;21(8):717-23. doi: 10.1080/08880010490514903.

Abstract

The authors investigated the diagnostic value of cerebrospinal fluid (CSF) soluble CD27 (sCD27) for leptomeningeal involvement of non-Hodgkin lymphomas (NHL). Cytospin slides were prepared from CSF samples of 64 children treated for NHL. sCD27 levels were determined by sandwich ELISA method using two CD27 monoclonal antibodies. 8/194 (4.1%) samples were considered tumor-positive by cytology. Mean sCD27 values were 5.8 and 13.8 U/mL in tumor-negative and tumor-positive samples, respectively (p =.18). 26/194 samples were false positive and 2/194 false negative (cutoff: 7 U/mL) (sensitivity, 75 %; specificity, 86%; positive predictive value, 18.8%; negative predictive value, 98.8%; accuracy, 85.6%). With these results, the value of adding sCD27 determination to the cytological CSF examination remains questionable.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Diagnostic Errors
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Infant
  • Lymphoma, Non-Hodgkin / cerebrospinal fluid*
  • Lymphoma, Non-Hodgkin / pathology
  • Male
  • Meningeal Neoplasms / cerebrospinal fluid
  • Meningeal Neoplasms / diagnosis*
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Statistical Distributions
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / cerebrospinal fluid*

Substances

  • Tumor Necrosis Factor Receptor Superfamily, Member 7